These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37078565)

  • 1. Expression of lncRNA DLX6-AS1 in patients with hepatic carcinoma and its prognostic value.
    Lin Y; Zhang B; Su L; Wei J; Chen Z; Wu M
    Biotechnol Genet Eng Rev; 2023 Apr; ():1-12. PubMed ID: 37078565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer.
    Ding XZ; Zhang SQ; Deng XL; Qiang JH
    Technol Cancer Res Treat; 2021; 20():1533033821990060. PubMed ID: 33550924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
    Tian S; Liu J; Kong S; Peng L
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis.
    Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y
    Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J; Liu HR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal long non-coding RNA DLX6-AS1 as a potential diagnostic biomarker for non-small cell lung cancer.
    Zhang X; Guo H; Bao Y; Yu H; Xie D; Wang X
    Oncol Lett; 2019 Nov; 18(5):5197-5204. PubMed ID: 31612030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells.
    Fu X; Tian Y; Kuang W; Wen S; Guo W
    Exp Ther Med; 2019 Jun; 17(6):4715-4722. PubMed ID: 31105791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
    Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
    J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
    Zhao Z; Liang S; Sun F
    Front Oncol; 2020; 10():1172. PubMed ID: 32850336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
    Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway.
    Zhang L; He X; Jin T; Gang L; Jin Z
    Biomed Pharmacother; 2017 Dec; 96():884-891. PubMed ID: 29145165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma.
    Yu S; Li N; Wang J; Fu Y; Huang Y; Yi P; Chen R; Tang D; Hu X; Fan X
    Clin Ther; 2020 Mar; 42(3):439-447. PubMed ID: 32070484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma.
    Li J; Li P; Zhao W; Yang R; Chen S; Bai Y; Dun S; Chen X; Du Y; Wang Y; Zang W; Zhao G; Zhang G
    Cancer Cell Int; 2015; 15():48. PubMed ID: 26052251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising long noncoding RNA DLX6-AS1 in malignant tumors.
    Xue C; Lv L; Jiang J; Li L
    Am J Transl Res; 2020; 12(12):7682-7692. PubMed ID: 33437353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.
    An Y; Chen XM; Yang Y; Mo F; Jiang Y; Sun DL; Cai HH
    Cancer Cell Int; 2018; 18():143. PubMed ID: 30250401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of long noncoding RNA DLX6-AS1 promotes cell growth and metastasis in esophageal squamous cell carcinoma via targeting miR-577.
    Wu SB; Wang HQ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1195-1201. PubMed ID: 32096208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
    Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
    Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway.
    Zhang N; Meng X; Mei L; Zhao C; Chen W
    J Cell Biochem; 2019 Jul; 120(7):11478-11489. PubMed ID: 30838699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.